Evidence map›Paper›PMID 30100904›Full record

ArticleFrontiers in immunology2018

iBCE-EL: A New Ensemble Learning Framework for Improved Linear B-Cell Epitope Prediction.

Balachandran Manavalan, Rajiv Gandhi Govindaraj, Tae Hwan Shin, Myeong Ok Kim, Gwang Lee

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 78 papers.

0numbers the graph read from it
0cells of the map it votes in
78citing papers in PubMed
8.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

78 citing papers in PubMed, 174 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Improving B-cell Linear Epitope PredictionCurrent drug targets · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Interpretable molecular encodings and representations for machine learning tasks.Computational and structural biotechnology journal · 2024
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Optimizing sheep B-cell epitopes inFrontiers in immunology · 2024
    Article
  17. Multi-perspectives and challenges in identifying B-cell epitopes.Protein science : a publication of the Protein Society · 2023
    Review
  18. Recent Progress in Antibody Epitope Prediction.Antibodies (Basel, Switzerland) · 2023
    Review
  19. Article
  20. Article

18 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Balachandran ManavalanDepartment of Physiology, Ajou University School of Medicine, Suwon, South Korea.
Rajiv Gandhi GovindarajDepartment of Biological Sciences, Louisiana State University, Baton Rouge, LA, United States.
Tae Hwan ShinDepartment of Physiology, Ajou University School of Medicine, Suwon, South Korea.
Myeong Ok KimDivision of Life Science and Applied Life Science (BK21 Plus), College of Natural Sciences, Gyeongsang National University, Jinju, South Korea.
Gwang LeeDepartment of Physiology, Ajou University School of Medicine, Suwon, South Korea.
Ajou University · KRGyeongsang National University · KRLouisiana State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Identification of B-cell epitopes (BCEs) is a fundamental step for epitope-based vaccine development, antibody production, and disease prevention and diagnosis. Due to the avalanche of protein sequence data discovered in postgenomic age, it is essential to develop an automated computational method to enable fast and accurate identification of novel BCEs within vast number of candidate proteins and peptides. Although several computational methods have been developed, their accuracy is unreliable. Thus, developing a reliable model with significant prediction improvements is highly desirable. In this study, we first constructed a non-redundant data set of 5,550 experimentally validated BCEs and 6,893 non-BCEs from the Immune Epitope Database. We then developed a novel ensemble learning framework for improved linear BCE predictor called iBCE-EL, a fusion of two independent predictors, namely, extremely randomized tree (ERT) and gradient boosting (GB) classifiers, which, respectively, uses a combination of physicochemical properties (PCP) and amino acid composition and a combination of dipeptide and PCP as input features. Cross-validation analysis on a benchmarking data set showed that iBCE-EL performed better than individual classifiers (ERT and GB), with a Matthews correlation coefficient (MCC) of 0.454. Furthermore, we evaluated the performance of iBCE-EL on the independent data set. Results show that iBCE-EL significantly outperformed the state-of-the-art method with an MCC of 0.463. To the best of our knowledge, iBCE-EL is the first ensemble method for linear BCEs prediction. iBCE-EL was implemented in a web-based platform, which is available at http://thegleelab.org/iBCE-EL. iBCE-EL contains two prediction modes. The first one identifying peptide sequences as BCEs or non-BCEs, while later one is aimed at providing users with the option of mining potential BCEs from protein sequences.

Indexed as

AlgorithmsAmino Acid SequenceComputational BiologyEpitope MappingEpitopes, B-LymphocyteHumansPeptidesPosition-Specific Scoring MatricesReproducibility of ResultsROC CurveSensitivity and SpecificityWorkflowEpitopes, B-LymphocytePeptidesB-cell epitopeensemble learningextremely randomized treegradient boostingimmunotherapy

Identifiers

PMID30100904
PMCPMC6072840
OpenAlexW2884557428

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.